Research graph
References from The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1172/jci117518
10.1172/jci117518 · External reference
10.1161/01.atv.13.12.1865
10.1161/01.atv.13.12.1865 · External reference
10.1093/ije/25.2.291
10.1093/ije/25.2.291 · External reference
10.2337/diacare.14.3.173
10.2337/diacare.14.3.173 · External reference
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
1979 · External reference
10.1152/physrev.1995.75.3.473
10.1152/physrev.1995.75.3.473 · External reference
10.1056/nejm199001253220403
10.1056/nejm199001253220403 · External reference
The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.
10.1210/edrv.19.4.0338 · 1998 · External reference
Hemodynamic actions of insulin.
1994 · External reference
10.1097/00041433-199506000-00007
10.1097/00041433-199506000-00007 · External reference
10.2337/diab.37.6.667
10.2337/diab.37.6.667 · External reference
10.1007/978-1-4757-1850-8_15
10.1007/978-1-4757-1850-8_15 · External reference
Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose.
10.2337/diab.36.10.1167 · 1987 · External reference
10.1046/j.1463-1326.1999.0010s1023.x · Admitted local publication
10.1093/ajcp/106.1.128
10.1093/ajcp/106.1.128 · External reference
Low density lipoprotein subclass patterns and risk of myocardial infarction.
10.1001/jama.1988.03410130125037 · 1988 · External reference
10.1016/0026-0495(92)90088-r
10.1016/0026-0495(92)90088-r · External reference
10.1172/jci114142
10.1172/jci114142 · External reference
10.1097/00041433-199706000-00004
10.1097/00041433-199706000-00004 · External reference
10.1007/bf01220632
10.1007/bf01220632 · External reference
Diabetic dyslipidaemia.
1998 · External reference
Influence of lipolysis on chylomicron clearance and HDL cholestol levels.
1998 · External reference
The pathogenesis of atherosclerosis: a perspective for the 1990s.
10.1038/362801a0 · 1993 · External reference
10.1016/s0002-9149(98)00033-2
10.1016/s0002-9149(98)00033-2 · External reference
10.1161/01.atv.18.11.1723
10.1161/01.atv.18.11.1723 · External reference
10.1007/bf00401766
10.1007/bf00401766 · External reference
10.1161/01.cir.88.2.381
10.1161/01.cir.88.2.381 · External reference
D’. Agostino RB Sr Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome.
1997 · External reference
10.1161/01.atv.17.11.2413
10.1161/01.atv.17.11.2413 · External reference
10.1161/01.cir.97.10.996
10.1161/01.cir.97.10.996 · External reference
10.1007/s001250050581
10.1007/s001250050581 · External reference
10.1161/01.cir.93.10.1809
10.1161/01.cir.93.10.1809 · External reference
10.1046/j.1463-1326.1999.0010s1017.x · Admitted local publication
10.1001/archfami.7.2.155
10.1001/archfami.7.2.155 · External reference
10.1146/annurev.iy.11.040193.004003
10.1146/annurev.iy.11.040193.004003 · External reference
10.2337/diacare.13.6.631
10.2337/diacare.13.6.631 · External reference
10.2337/diab.45.3.s45
10.2337/diab.45.3.s45 · External reference
10.2337/diabetes.47.4.507
10.2337/diabetes.47.4.507 · External reference
Peroxisome proliferator‐activated receptor (PPAR) gamma: adipose‐predominant expression and induction early in adipocyte differentiation.
10.1210/endo.135.2.8033830 · 1994 · External reference
10.1016/0092-8674(94)90006-x
10.1016/0092-8674(94)90006-x · External reference
10.1016/s0092-8674(00)81575-5
10.1016/s0092-8674(00)81575-5 · External reference
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator‐activated receptor γ (PPARγ).
10.1074/jbc.270.22.12953 · 1995 · External reference
10.1056/nejm199411033311803
10.1056/nejm199411033311803 · External reference
10.1056/nejm199803263381303
10.1056/nejm199803263381303 · External reference
Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.
10.1001/archinte.1997.00440370028004 · 1997 · External reference
Unresolved reference
External reference
Promising new approaches.
1999 · External reference
PPARγ agonists inhibit production of monocyte inflammatory cytokines.
10.1038/34184 · 1998 · External reference
Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.
10.1210/endo.130.1.1727716 · 1992 · External reference
10.1016/s0092-8674(00)81574-3
10.1016/s0092-8674(00)81574-3 · External reference
10.1073/pnas.95.13.7614
10.1073/pnas.95.13.7614 · External reference
10.2337/diabetes.47.8.1193
10.2337/diabetes.47.8.1193 · External reference
10.1016/0140-6736(93)91651-2
10.1016/0140-6736(93)91651-2 · External reference
Locatelli
1998 · External reference
10.1007/s001250050822
10.1007/s001250050822 · External reference
Role of insulin resistance in human disease.
10.2337/diab.37.12.1595 · 1988 · External reference
10.1161/01.atv.11.4.1068
10.1161/01.atv.11.4.1068 · External reference
Arterial thrombosis and atherosclerosis in diabetes.
1997 · External reference
10.2337/diab.46.2.s9
10.2337/diab.46.2.s9 · External reference
